1. Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation
by Christopher Bredeson, Jennifer LeRademacher, Kazunobu Kato, John F. DiPersio, Edward Agura, Steven M. Devine, Frederick R. Appelbaum, Marcie R. Tomblyn, Ginna G. Laport, Xiaochun Zhu, Philip L. McCarthy, Vincent T. Ho, Kenneth R. Cooke, Elizabeth Armstrong, Angela Smith, J. Douglas Rizzo, Jeanne M. Burkart, and Marcelo C. Pasquini
Blood
Volume 122(24):
December 5, 2013
©2013 by American Society of Hematology

2. Outcomes of allogeneic HCT with IV-BU or TBI conditioning regimens.
Outcomes of allogeneic HCT with IV-BU or TBI conditioning regimens. (A) Survival by conditioning regimens. (B) Progression free survival by conditioning regimens. (C) Cumulative incidence of TRM by conditioning regimens. (D) Cumulative incidence of disease relapse by conditioning regimens.
Christopher Bredeson et al. Blood 2013;122:
©2013 by American Society of Hematology

3. Survival after allogeneic HCT with IV-BU or TBI conditioning stratified on diagnosis and disease status.
Survival after allogeneic HCT with IV-BU or TBI conditioning stratified on diagnosis and disease status. (A) Survival by diagnosis and conditioning regimens. (B) Survival by disease status and conditioning regimens
Christopher Bredeson et al. Blood 2013;122:
©2013 by American Society of Hematology